CORT
CORT
US2183521028
Corcept Therapeutics Incorporat
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
13.1B EUR
9.38B EUR
4.33B EUR
3.69B EUR
Enterprise Value
12.52B EUR
9.28B EUR
4.23B EUR
3.57B EUR
Valuation Multiples
Trailing P/E
269.31x
170.05x
91.38x
46.62x
Forward P/E
27.53x
--
--
--
Price to Sales
15.77x
11.29x
5.63x
6.1x
Price to Book
18.53x
13.3x
6.78x
5.69x
EV/Revenue
15.06x
11.17x
5.5x
5.91x
EV/EBITDA
1,548.15x
1,051.8x
--
83.47x
Price to FCF (P/FCF)
169.27x
87.76x
36.01x
26.89x
EV/FCF
161.71x
86.81x
35.18x
26.06x
FCF Yield
0.59%
1.14%
2.78%
3.72%
ende